摘要: Good-quality outcomes in asthma hinge not just on the availability of medications but also their appropriate use by patients: optimal "self-management." In asthma, low rates adherence to prophylactic (preventer) medication are associated with higher hospitalization and death. Many patients choose take because they perceive it be unnecessary or concerned about potential adverse effects. Approximately one third have strong concerns effects from inhaled corticosteroids (ICS). These related experience local symptoms attributed ICS side effects, include more abstract future, arising belief that regular will result long-term dependence. We need effective ways eliciting addressing patients' ICS. The development options an improved safety profile remains a key objective. However, ideal solution is pharmacologic. communicating relative benefits risks order facilitate informed adherence. Clinicians must prepared work ongoing partnership ensure offered clear rationale as why necessary address This approach, based detailed examination perspectives its treatment, open, nonjudgmental manner part clinician, consistent idea concordance.